A Failed Study & A Higher Approval Bar For Amylin
2 CommentsBy Ed Silverman // March 3rd, 2011 // 12:22 pm
| S | M | T | W | T | F | S |
|---|---|---|---|---|---|---|
| « Feb | Apr » | |||||
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 | ||
• Pharma Blog » 2011 » March
Pharmalot March 3rd, 2011 Archive
J&J’s Risperdal Consta Is Not Worth The Money?
2 CommentsBy Ed Silverman // March 3rd, 2011 // 7:46 am
Amgen Execs Take The 5th Over Alleged Kickbacks
8 CommentsBy Ed Silverman // March 3rd, 2011 // 7:03 am
Astellas Loses Lawsuit Against French Med Journal
1 CommentBy Ed Silverman // March 3rd, 2011 // 7:01 am